An effective drug exists - but the young cancer patients are discriminated against Israel today. More than half of the patients diagnosed with Hodgkin's lymphoma are 15-40 years old.
Despite this, the public funding for the drug Edestris, which has been proven to be effective, is only given to patients over 60. "Khalasartan" association: "Fix the discrimination" . "I would be happy if this treatment were in the basket for the patients," Gal Shaham, 19, says.